Picture of Eocene logo

EOCN — Eocene News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Results Of Galmed's Phase 2B Arrest Trial Of Aramchol Published In Nature Medicine

Oct 11 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * RESULTS OF GALMED'S PHASE 2B ARREST TRIAL OF ARAMCHOL
PUBLISHED
IN NATURE MEDICINE
    * GALMED PHARMACEUTICALS LTD - A PHASE 3 PROGRAM IS
CURRENTLY
ONGOING WITH A HIGHER DAILY ARAMCHOL DOSE

Source text for Eikon:  ID:nPn9VCVMXa 
Further company coverage:  GLMD.O

Recent news on Eocene

See all news